Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAspirin dosage for the prevention of graft occlusion in people undergoing coronary surgeryCost-effectiveness of revascularization strategies: the ASCERT studyLong-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI.CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.Neurological complications of cardiac surgery.Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease.Dementia and depression with ischemic heart disease: a population-based longitudinal study comparing interventional approaches to medical management.Composite outcomes in coronary bypass surgery versus percutaneous intervention.Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Intervention in Older Persons with Acute Coronary Syndrome-Part II.Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.Low-level-laser irradiation induces photorelaxation in coronary arteries and overcomes vasospasm of internal thoracic arteries.Risk-benefit trade-offs in revascularisation choices.Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.Coronary revascularization in diabetic patients: Current state of evidence.Impact of repeated percutaneous coronary intervention on long-term survival after subsequent coronary artery bypass surgery.Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis.Long-term mortality of coronary artery bypass grafting and bare-metal stenting.Determinants of variations in coronary revascularization practices.Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of KoreaDeterminants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventionsDeterminants of variations in initial treatment strategies for stable ischemic heart disease.Comparative effectiveness of revascularization strategiesOutcomes of Primary Percutaneous Coronary Intervention for Patients with Previous Coronary Artery Bypass Grafting Presenting with STsegment Elevation Myocardial Infarction.Long-term Outcome after Percutaneous Coronary Intervention Compared with Minimally Invasive Coronary Artery Bypass Surgery in the ElderlyLessons from the SYNTAX trial.Optimal method of coronary revascularization in patients receiving dialysis: systematic review.Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stentsMultivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.Therapeutic options in coronary artery disease: focusing on the guidelines.Long-term survival after coronary bypass surgery and percutaneous coronary intervention.The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.CABG in 2012: Evidence, practice and the evolution of guidelinesCurrent options for treatment of chronic coronary artery diseaseLong-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.Interventional Revascularization of Coronary Artery Lesions in Diabetic Patients; In-hospital and One Year Follow upCurrent concepts on coronary revascularization in diabetic patients.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiRevascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials.Cardiac surgery versus stenting: what is better for the patient?
P2860
Q22241786-A7523B76-3633-4990-86E5-A169B7A2B944Q24186070-988AD05E-EC49-4EAA-8DF1-7673F5840284Q28111825-CD2FCA32-29FF-4AE8-B569-37D2469E6FA8Q30414389-1944B74F-4D09-43A1-977B-10861C89038FQ30855875-92BB27DD-FD09-4449-920F-740302A2E0FCQ33396480-CC42E49F-9B31-4D1D-95A6-A1BA2BB63C9CQ33740804-722627DC-E006-4789-B029-C49351761552Q33841043-EA659638-212C-4DCD-8949-842D6F9EB1D5Q33924170-9D9F489E-CB7F-482E-B30B-4E2D27F0FFCCQ33955828-C6A3315B-12CE-4DBA-A77B-BF38A6BE1293Q33971106-895A8042-E358-47F2-865B-4FB3F28A3448Q34420687-4F4DC616-AE70-446B-A22B-C15A54B3C9EBQ34700769-7659D2F7-176B-4964-833B-38A0DEE552ECQ34771915-D3B49663-9AF1-4312-9543-9EEFA8757642Q34789840-7608FB48-D26D-4C2F-B9D2-19DC9AAB58C9Q35248194-26470EAF-B2A2-46AF-90DE-7C7F5090B910Q35619894-20FDA427-FBB8-46F3-AF13-6324980F2216Q35734651-778149BF-4063-485F-B721-CF753D4A58C2Q35739868-0AE3A6E0-4EBC-47FB-BD21-F9CB379FDA25Q35778266-58C6400C-24DE-468B-BDAA-291F18010ECCQ35822159-B357A59A-32E4-43BC-9D78-F128DB25F556Q35847120-7B169A24-772A-484D-A00E-2CAEA2FABF9EQ36351313-DC4DA795-6D8C-4796-9A1D-5D1D7EE332EFQ36622929-55C183DF-C3E9-4CF1-A01B-07A167B05409Q36658583-12D02775-B010-48D1-918C-F8827EE09586Q37055812-2854AEBE-15B7-4EB3-8492-A3E94632A233Q37087920-6047FB12-4FDA-4068-994A-A299E942F48DQ37130698-9034AA35-9D77-4704-BE9B-510FD6200C7EQ37188126-22342CDC-CA63-46FD-8E93-7345599092E0Q37215480-78330B32-0BD3-4C5F-9333-6B4A25413B75Q37390057-E23DBA4A-65C6-44FD-BCB3-F6B8F57706A0Q37390795-6F5928DF-3662-4A17-AC50-C71C16D4B95AQ37659163-C574EBF1-AF78-4FD9-9875-C2470A78EDC9Q37663898-BC0E1ADC-339B-416F-982B-236B23DC4394Q37685137-71F30136-10FC-438E-92B0-5DEC446B3DFAQ37703974-F4505568-986E-4B30-AD0F-40BC40D564CCQ37926750-77304DD1-C8FC-46BA-A9AE-09973CC0B3C9Q37953885-B410D26E-0867-4F01-B921-78573A0C1F96Q38013670-836116F5-C07B-4DC8-9698-07C91139CEA8Q38044498-6B22858D-E900-4BB3-B240-8F972B6BA8FB
P2860
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@ast
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@en
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@nl
type
label
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@ast
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@en
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@nl
prefLabel
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@ast
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@en
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@nl
P2093
P356
P1476
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
@en
P2093
Alfred T Culliford
Chuntao Wu
Craig R Smith
Edward L Hannan
Gary Walford
Jeffrey P Gold
Robert H Jones
Robert S D Higgins
Russell E Carlson
P304
P356
10.1056/NEJMOA071804
P407
P577
2008-01-24T00:00:00Z